Santa Cruz
Santa Cruz Biotechnology, Inc. is focused on the ongoing development of research antibodies. It is our goal to continue to offer the broadest range of research reagents in the field. We provide superior, innovative primary antibodies and support products. Santa Cruz Biotechnology has the highest commitment to quality and customer service. Please contact us if we can assist you in your research needs.
www.scbt.com
R&D Systems
R&D Systems was founded in 1976 in Minneapolis, MN. It is a wholly owned subsidiary of TECHNE Corporation (a holding company with no employees). The stock is traded publicly on NASDAQ’s National Market System under the “TECH” symbol. TECHNE has two operating
subsidiaries: Research & Diagnostics Systems, Inc. (R&D Systems) and R&D Systems Europe Ltd. R&D Systems has two operating divisions: Biotechnology, which manufactures reagents primarily for the research market, and Hematology, which manufactures controls and
calibrators for hematology analyzers.
Key Product & Services
• Biotechnology Division: - Proteins - Antibodies - ELISAs - Multiplex Assays/Arrays
- Activity Assays & Reagents - Stem Cell & Cell Culture Products - ELISpot Kits and Development Modules - Flow Cytometry & Cell Selection/Detection - General Laboratory Reagents - Assay Services (Analytical Testing Service and Custom Assay
Development)
• Hematology Division: - Controls - Calibrators - Linearity Materials - Survey Materials - Interlaboratory Quality Control Program
www.rndsystems.com
Bethyl
Since 1972, Bethyl has provided quality antibody products and services for both clinical and research applications. We remain committed to manufacturing new and novel antibodies to facilitate and accelerate your discovery based research in cell biology. To ensure the quality of our antibodies, all antibodies are produced and a nity puri ed by antigen speci c a nity chromatography at our sole facility in Montgomery, TX. Through our collaborations and scholarly searches we continue to identify new and emerging proteins of interests. We are aggressively producing antibodies to these new proteins as well as those classic proteins for which there is a dearth of quality antibodies. We test our antibodies in a wide range of applications including ELISA, western blot, immunoprecipitation, immunohistochemistry and immunocytochemistry. Bethyl Laboratories is a Registered Research Facility with the USDA under the Animal Welfare Act and complies daily with all requirements of the Act. Bethyl Laboratories, Inc. operates under Good Manufacturing Practices.
http://www.bethyl.com
QED Bioscience
QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. We develop these antibodies using the client's small molecule, protein, or peptide targets, or by utilizing the target cDNA. We are a full - service corporation, and offer additional immunochemistry services such as purification and conjugation so that we can provide our clients with an antibody product that will work specifically within their system. We also develop monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.
www.qedbio.com
PBL Interferon
Founded in 1990 by Sidney Pestka, M.D., PBL InterferonSource has become the premier supplier of reliable high-quality interferon products.
We have grown each and every year since 1998, when we began direct sales to customers like you. PBL started as a family business.
Although we have grown substantially since that time, we have made it a point to retain the values that we grew up with: a single-minded
focus on our scienti c mission and business goals; and a particular concern for and commitment to each of our customers. We are also
pleased to be able to support the mission of our "sister company" PBL Therapeutics, which is focused on developing interferon-based drugs
to treat cancer.
PBL's goal has always been to facilitate the advancement of research. To that end, each year we aim to increase the quality and quantity of
our products, to supplement our store of product information, and to provide scientists around the world with the support they require.
www.interferonsource.com
Miltenyi
Miltenyi Biotec, founded in 1989, has grown to over 1100 employees in 18 countries. The company develops, manufactures, and sells more than 1000 products and services; particularly in the elds of cell biology, immunology, regenerative medicine, and molecular biology. Miltenyi Biotec is committed to the advancement of scienti c understanding and medicine by providing products and services for biomedical research and cellular therapy.
Miltenyi Biotec developed MACS® Technology, the gold standard method in magnetic cell separation. The ease and speed of the procedure combined with high purity and yield are only two of its many advantages. MACS Technology combines the use of MACS MicroBeads (nano-sized superparamagnetic particles coupled to speci c antibodies), patented MACS Columns, and MACS Separators (strong permanent magnets). MACS Technology o ers a multitude of applications: from small-scale to large-scale cell puri cations, from cell to biomolecule separations, from lab bench to clinical research applications and separation of adult stem cells – for example, with the CliniMACS® Cell Separation System.
www.miltenyibiotec.com
Vector Lab
When Vector Laboratories was founded more than 30 years ago, monoclonal antibodies, biotin-avidin products or lines of lectins were not available in the marketplace. In 1976, we purified the first line of lectins and quickly became the world’s leading supplier of these products for use in studying glycoconjugates in tissues, on cells, or isolated from fluids or extracts. In our second year we introduced the Biotin-Avidin System. Realizing that the strong interaction between biotin and avidin could be utilized to form nearly covalent linkages between a molecule derivatized with biotin and avidin conjugated with a detectable label, we provided the research community with the first set of Biotin-Avidin System reagents.
These first products, consisting of biotinylated proteins and avidin conjugates, began a revolution in detection methods. Our biotinylated anti-mouse immunoglobulin and labeled avidin proved to be the most widely used reagents for detecting and characterizing monoclonal antibodies. After several years, other companies recognized their importance and began offering their own versions of these products. More than twenty years ago, we developed and patented processes that enabled complexes between avidin or streptavidin and biotinylated enzymes, designated ABC’s, to be formed. This achievement established the basis for the VECTASTAIN®ABC family of products. While other detection systems produced faint or diffuse staining in tissue sections and required high concentrations of primary antibodies, the VECTASTAIN®ABC system gave dark, discrete, background-free staining with extremely low concentrations of primary anti-bodies. Improvements over the years led to the VECTASTAIN®Elite ABC - widely recognized today as the most sensitive, reliable and economical peroxidase-based staining system available.
After several years of development we introduced the ImmPRESS™ Reagents. These new reagents are not based on biotin/avidin technology but rely on a novel method of polymerizing peroxidase "micropolymers" directly to secondary antibodies. Expanding on our expertise in non-radioisotopic detection methods, we have developed new and improved ways of labeling nucleic acid probes. PHOTOPROBE®Biotin is used to randomly label any nucleic acid with biotin. The FastTag®labeling system allows nucleic acid to be easily and economically labeled with any marker. The 3’ EndTag™ and 5’ EndTag™ system provide simple methods to label only the ends of nucleic acid probes.
www.vectorlabs.com
Abbiotec
Abbiotec is a company focused on developing and commercializing next generation antibodies and reagents for the life science research community. Our approach and business concepts were born out of a need and our strong desire to deliver antibodies against druggable proteins. Our proprietary technologies allow us to select, design, and produce antibodies, lysates, and various reagents with a high degree of skill and e ciency so researchers can better focus their energies on their experimental designs and ideas. Abbiotec is a di erent type of reagent company for a new century of demanding and exciting research projects and ideas. Our tools enable the study of human biology and disease at the cellular and molecular levels, with cross applications in diagnostic assays that we hope may eventually lead to promising therapeutics.
Abbiotec begins by o erings a large library of unique antibodies targeted against high value druggable proteins. Our aim is to eventually build the most comprehensive and valuable library of antibodies and related reagents that target the estimated 4,000 human disease proteins. Abbiotec will also o er various complementary kits and solutions in the areas of genomics, proteomics, cell and tissue culture, and areas important for studies in functional genomics, signaling pathways, immunology, cancer, and brain disorders. Abbiotec backs all of its reagents with unparalleled customer service and professionalism. Every product is provided with ample documentation and is backed with the necessary data. At Abbiotec, we believe that a strong relationship with our research community is the surest way to show our dedication and pride in our work and to allow for the maximum of success and satisfaction to our customers.
www.abbiotec.com
GenWay Biotech
As a protein and antibody solutions provider, GenWay has a multi-functional technology platform specialized in using genes, proteins, antibodies, and their applications in cells, tissues and animal models, for functional genomics and proteomics. GenWay’s core competencies enable the Company to carry out bioinformatic analyses of protein targets, produce high-quality protein antigens and ligands, and develop domain-speci c IgY antibodies for immunoa nity capture, partitioning, detection and analyses. The Company can also provide downstream proteomic analyses, target validation, and diagnostic product development.
www.genwaybio.com
Meridian Life Science, Inc. is a wholly owned subsidiary of Meridian Bioscience, Inc. Meridian Bioscience entered the life science market primarily through its acquisitions of: - BIODESIGN International (a subsidiary of Gull Laboratories) in 1998 - Viral Antigens, Inc. in 2000 - OEM Concepts, Inc. in 2005 Meridian Life Science is a leading manufacturer and supplier of antibodies, viral antigens and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with cGMP biologics manufacturing for the biopharmaceutical market. We have been providing innovative life science solutions and building trusted partnerships for over 25 years.
Our focus is to o er products and services that help to advance the diagnosis and treatment of disease. Contract manufacturing of proteins and other biologicals for biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines is an example of signi cant new product applications built from Meridian Life Science’s existing expertise in manufacturing bulk antigens and reagents using cell culture techniques. This business focuses on cGMP contract manufacturing of materials that will be used in Phase I and II clinical trials. The life science operating segment has targeted three primary market segments for its products and services: - bulk biomedical reagents - drug and vaccine discovery - drug and vaccine development
www.meridianbioscience.com
Alpco Diagnostic
ALPCO (American Laboratory Products Company) was founded in 1990 as an importer and distributor of high quality research immunoassay kits. Since that time, our primary goals have been to o er a diverse line of assays that appeal to our broad customer base while also providing exceptional customer service and product support. In recent years, ALPCO has solidi ed its place in the market not only as a distributor but as a developer and manufacturer of immunoassays as well. Much of this successful growth can be attributed to the ongoing communication and collaborative relationships that we have fostered with our customers and respected thought leaders in the academic, biotech and clinical arenas.
www.alpco.com
Bioporto Diagnostic
BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector. The Company’s developments include a test (NGAL) to diagnose and monitor acute kidney damage. BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases.
BioPorto was founded in 2000 and has about 25 employees. The Company’s shares are listed on NASDAQ OMX Copenhagen (symbol: BIOPOR).
www.antibodyshop.dk
Covance Covance — one of the world's largest and most comprehensive drug development services companies — has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges. We provide a portfolio of preclinical and clinical development and commercial service offerings — delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals.
www.covance.com
Vivantis
Vivantis is a research-based biotechnology company incorporated in 2002. We specialize in the production of Restriction Enzymes, DNA extraction kits, DNA ampli cation reagents and other related products for molecular biology research. Our products stem from research done in-house to provide integrated solutions to life science researchers world wide. We ensure a constant stream of pioneering innovations from our experienced scientists in our R & D team. This includes kits for molecular biology applications, recombinant enzymes, improved protein stains, markers and ladders.
www.vivantis.com